Description: Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It primarily focuses on the therapeutic areas, including oncology, regenerative medicine, and inflammatory disease. The company offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. Hadasit Bio-Holdings Ltd was founded in 2005 and is based in Jerusalem, Israel.
Home Page: www.hbl.co.il
Jerusalem Bio-Park
Jerusalem,
91120
Israel
Phone:
Officers
| Name | Title |
|---|---|
| Mr. Yoram Azulai | CFO, VP of Fin., Acting CEO & Company Sec. |
| Mr. Oren Levy | Sr. Deputy Director Gen. & Director |
| Mr. Alejandro Igelman | VP of Fin. |
Exchange: TA
Country: IL
Currency: Israeli Agora (ILA)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0.5923 |
| Price-to-Book MRQ: | 0.5156 |
| Price-to-Sales TTM: | 0.8996 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2 |